Literature DB >> 27816364

In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model.

Azusa Maeda1, Yonghong Chen2, Jiachuan Bu2, Hilda Mujcic2, Bradly G Wouters3, Ralph S DaCosta4.   

Abstract

PURPOSE: To investigate the effect of high-dose irradiation on pancreatic tumor vasculature and microenvironment using in vivo imaging techniques. METHODS AND MATERIALS: A BxPC3 pancreatic tumor xenograft was established in a dorsal skinfold window chamber model and a subcutaneous hind leg model. Tumors were irradiated with a single dose of 4, 12, or 24 Gy. The dorsal skinfold window chamber model was used to assess tumor response, vascular function and permeability, platelet and leukocyte adhesion to the vascular endothelium, and tumor hypoxia for up to 14 days after 24-Gy irradiation. The hind leg model was used to monitor tumor size, hypoxia, and vascularity for up to 65 days after 24-Gy irradiation. Tumors were assessed histologically to validate in vivo observations.
RESULTS: In vivo fluorescence imaging revealed temporary vascular dysfunction in tumors irradiated with a single dose of 4 to 24 Gy, but most significantly with a single dose of 24 Gy. Vascular functional recovery was observed by 14 days after irradiation in a dose-dependent manner. Furthermore, irradiation with 24 Gy caused platelet and leukocyte adhesion to the vascular endothelium within hours to days after irradiation. Vascular permeability was significantly higher in irradiated tumors compared with nonirradiated controls 14 days after irradiation. This observation corresponded with increased expression of hypoxia-inducible factor-1α in irradiated tumors. In the hind leg model, irradiation with a single dose of 24 Gy led to tumor growth delay, followed by tumor regrowth.
CONCLUSIONS: Irradiation of the BxPC3 tumors with a single dose of 24 Gy caused transient vascular dysfunction and increased expression of hypoxia-inducible factor-1α. Such biological changes may impact tumor response to high single-dose and hypofractionated irradiation, and further investigations are needed to better understand the clinical outcomes of stereotactic body radiation therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27816364     DOI: 10.1016/j.ijrobp.2016.09.005

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Deletion of Atm in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung Adenocarcinoma.

Authors:  Jordan A Torok; Patrick Oh; Katherine D Castle; Michael Reinsvold; Yan Ma; Lixia Luo; Chang-Lung Lee; David G Kirsch
Journal:  Cancer Res       Date:  2018-10-12       Impact factor: 12.701

Review 2.  Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology.

Authors:  William A Hall; Mandana Kamgar; Beth A Erickson; Sara Beltrán Ponce; Susan Tsai; Marja T Nevalainen; Kathleen K Christians; Ben George; Kulwinder S Dua; Abdul H Khan; Douglas B Evans; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2021-10-06       Impact factor: 9.237

3.  Challenges and opportunities of using stereotactic body radiotherapy with anti-angiogenesis agents in tumor therapy.

Authors:  Xiaowen Sun; Lei Deng; You Lu
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

Review 4.  Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.

Authors:  Maria Esperanza Rodriguez-Ruiz; Ilio Vitale; Kevin J Harrington; Ignacio Melero; Lorenzo Galluzzi
Journal:  Nat Immunol       Date:  2019-12-23       Impact factor: 25.606

5.  Preclinical longitudinal imaging of tumor microvascular radiobiological response with functional optical coherence tomography.

Authors:  Valentin Demidov; Azusa Maeda; Mitsuro Sugita; Victoria Madge; Siddharth Sadanand; Costel Flueraru; I Alex Vitkin
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

Review 6.  Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives.

Authors:  Niall M Byrne; Prajakta Tambe; Jonathan A Coulter
Journal:  J Pers Med       Date:  2021-01-16

Review 7.  Advances in Hypofractionated Irradiation-Induced Immunosuppression of Tumor Microenvironment.

Authors:  Yuxia Wang
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

Review 8.  Therapeutic targeting of the hypoxic tumour microenvironment.

Authors:  Dean C Singleton; Andrew Macann; William R Wilson
Journal:  Nat Rev Clin Oncol       Date:  2021-07-29       Impact factor: 66.675

Review 9.  Symptom Management in Pancreatic Cancer.

Authors:  Kristina G Lee; Varun Roy; Meghan Laszlo; Katelyn M Atkins; Katrina J Lin; Shant Tomassian; Andrew E Hendifar
Journal:  Curr Treat Options Oncol       Date:  2021-01-02

Review 10.  The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules.

Authors:  Kimberly M Arnold; Nicole J Flynn; Adam Raben; Lindsay Romak; Yan Yu; Adam P Dicker; Firas Mourtada; Jennifer Sims-Mourtada
Journal:  Cancer Growth Metastasis       Date:  2018-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.